| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/2004 | US20040053306 Comprises nucleotide sequences proteins for diagnosing and treating diabetes, arthritis, inflammation, skin and adult respiratory distress syndrome |
| 03/18/2004 | US20040053304 Methods and compositions for detecting cancers |
| 03/18/2004 | US20040053301 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 03/18/2004 | US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 03/18/2004 | US20040053297 Cytokine-like proteins |
| 03/18/2004 | US20040053292 Comprises nucleotide sequences coding polypeptide containing signal peptide sequences for treatment and prevention of psoriasis, asthma, artheriosclerosis, infections, meningitis, pneumonia and multiple sclerosis |
| 03/18/2004 | US20040053291 Nucleic acid-associated proteins |
| 03/18/2004 | US20040053288 Method for estimating therapeutic efficacy of tumor necrosis factor |
| 03/18/2004 | US20040053285 Plant transcription factors |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053276 Comprises protein factors for diagnosis, prevention and treatment of cancers, infections, immunological, gastrointestinal, organ and endocrine disorders; animal models for disease |
| 03/18/2004 | US20040053266 Protein with cap-and cellulose- binding activity |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053261 Identifying allelic sequence whch can be used to diagnose and treat urogenital cancers |
| 03/18/2004 | US20040053258 Transporters and ion channels |
| 03/18/2004 | US20040053252 Secreted redox proteins |
| 03/18/2004 | US20040053250 Novel arginine-rich protein-like nucleic acids and polypeptides |
| 03/18/2004 | US20040053249 Fas ligand-fused proteins |
| 03/18/2004 | US20040053248 Novel nucleic acids and polypeptides |
| 03/18/2004 | US20040053247 Markers for prostate cancer |
| 03/18/2004 | US20040053245 Comprises nucleotide sequences coding protein factor for diagnosing and treating neurodegenerative, bone, muscle, cardiovascular and pancreatic disorders |
| 03/18/2004 | US20040053244 Regulation of human galanin receptor-like g protein coupled receptor |
| 03/18/2004 | US20040053241 Enzymatic amino acid sequences for preventing protein degradation; mimetic enzyme inhibitors and drug design; developing genetic vaccines |
| 03/18/2004 | US20040053240 Molecules associated with human reproduction |
| 03/18/2004 | US20040053233 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 03/18/2004 | US20040053231 Comprises nucleotide sequences coding cbp/p3000 interacting transativators with ed-rich tails (HCITED) diagnosis, prevention and treatment hypoxia, cardioovascular, inflammatory, cancer and stroke disorders |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040053221 Diagnosing pneumocystis infection in immunocomprised individuals; immunoassay |
| 03/18/2004 | US20040053210 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 03/18/2004 | US20040053206 Using tissue preservation solution to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
| 03/18/2004 | US20040052928 A peptide containing at least 5 amino acid residues and less than 15 amino acid residues; |
| 03/18/2004 | US20040052869 Orally ingestible preparation of mistletoe lectins and method |
| 03/18/2004 | US20040052833 Contacting infectious proteins with a salt of an alkyl sulfate (sodium dodecylsulfate) allowing the proteins to remain in contact with alkyl sulfate salt for a specific time and temp. so as to render proteins noninfectious |
| 03/18/2004 | US20040052821 HIV envelope polypeptides and vaccine |
| 03/18/2004 | US20040052820 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 03/18/2004 | US20040052819 Addition of histidine amino acids to the cytoplasmic domains of membrane and viral envelope proteins for the purpose of solubilizing, and/or reconstituting viral envelope proteins in lipid containing vesicles |
| 03/18/2004 | US20040052818 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 03/18/2004 | US20040052817 A nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052813 Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits and the diagnostic kits |
| 03/18/2004 | US20040052812 Immunogenic complex containing a multi-component viral particle covalently linked to a javelin molecule, wherein the javelin molecule is a peptide which selectively binds to a heat shock protein |
| 03/18/2004 | US20040052811 Vaccine against cancer diseases that are associated with the her-2/neu oncogene |
| 03/18/2004 | US20040052810 Fusion protein; antitumor agents, antidiabetic agents, wound healing agents, antiulcer agents |
| 03/18/2004 | US20040052809 Atherosclerosis; apolipoproteins; induce immunology response |
| 03/18/2004 | US20040052807 Synthetic vaccine for tick control |
| 03/18/2004 | US20040052806 Proteins and nucleic acids encoding same |
| 03/18/2004 | US20040052799 Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |
| 03/18/2004 | US20040052794 Isolation antibodies; anticancer agents, antitumor agents |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052788 Cytokine that induces apoptosis |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052782 Semaphorin proteins; dendritic cells; gene expression; isolated antibodies; therapy for autoimmune disease |
| 03/18/2004 | US20040052781 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/18/2004 | US20040052777 Therapy for vision defects; angiogenesis inhibition |
| 03/18/2004 | US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering |
| 03/18/2004 | US20040052770 Interleukin-secreting natural killer cell lines and methods of use |
| 03/18/2004 | US20040052767 Method for cell adhesion and wound healing |
| 03/18/2004 | US20040052766 Alzheimer's disease vaccine; induction antibodies, antigens |
| 03/18/2004 | US20040052765 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering |
| 03/18/2004 | US20040052758 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 03/18/2004 | DE10305607A1 Immunogene MUC1-Glykopeptide Immunogenic MUC1 glycopeptides |
| 03/18/2004 | DE10242763A1 New polynucleotide encoding mutant human glucose transporter, useful for identifying antidiabetic agents that can be used to treat diabetes types I or II |
| 03/18/2004 | DE10242318A1 Orthopoxvirusantigene und deren Verwendung Orthopoxvirusantigene and their use |
| 03/18/2004 | DE10241553A1 New variants of the human Tissue Inhibitor Of Metalloproteinase-2 and Matrix Metalloproteinase-2 genes, for diagnosis of pathologically abnormal gene expression, and use of normal gene sequences in gene therapy |
| 03/18/2004 | DE10240866A1 New polypeptide that binds immunoglobulin E and alters cytokine synthesis, useful for treating e.g. atopic eczema, asthma or allergy, also its encoding nucleic acid |
| 03/18/2004 | DE10130985B4 Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente A method for the diagnosis of sepsis and severe infections by determining soluble cytokeratin-1 fragments |
| 03/18/2004 | CA2498476A1 Type 2 diabetes susceptibility genes |
| 03/18/2004 | CA2498353A1 Antifreeze proteins isolated from forage grasses and methods for their use |
| 03/18/2004 | CA2498319A1 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2498284A1 Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| 03/18/2004 | CA2497972A1 Hbv precore protein having a particle-forming ability |
| 03/18/2004 | CA2497960A1 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497833A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | CA2497794A1 Modified glp-1 receptor agonists and their pharmacological methods of use |
| 03/18/2004 | CA2497777A1 Modified asialo-interferons and uses thereof |
| 03/18/2004 | CA2497750A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497696A1 Increasing the absorption of substances via the skin and mucous membranes |
| 03/18/2004 | CA2497660A1 Allergy vaccines |
| 03/18/2004 | CA2497497A1 Regulators for implantation |
| 03/18/2004 | CA2497477A1 Method of designing physiologically active peptide and use thereof |
| 03/18/2004 | CA2497338A1 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same |
| 03/18/2004 | CA2497254A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 03/18/2004 | CA2497209A1 Process for protein extraction |
| 03/18/2004 | CA2496891A1 Novel actin-related cytoskeletal protein lacs |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496760A1 Method for improving corn starch extractability |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2496400A1 Bh3 peptides and method of use thereof |
| 03/18/2004 | CA2495895A1 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/18/2004 | CA2495825A1 Variants of the major allergen phl p 1 from timothy grass |
| 03/18/2004 | CA2407301A1 Hsp60 sequence from piscirickettsia salmonis |
| 03/17/2004 | EP1398632A1 P2y11 receptor agonists and the use in the field of erythropoiesis |
| 03/17/2004 | EP1398389A2 Variant of HNF-1alpha gene having a single nucleotide polymorphism and variant of protein encoded by the same |
| 03/17/2004 | EP1398385A1 Assay using marked microbial host cell strains |
| 03/17/2004 | EP1398380A1 Orthopoxvirus antigens and use thereof |